Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Levosalbutamol hydrochloride (substance) |
Is a |
False |
Levosalbutamol |
Inferred relationship |
Some |
|
Levalbuterol 0.31mg/3mL inhalation solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levosalbutamol |
Inferred relationship |
Some |
|
Levalbuterol 0.63mg/3mL inhalation solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levosalbutamol |
Inferred relationship |
Some |
|
Levalbuterol 1.25mg/3mL inhalation solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levosalbutamol |
Inferred relationship |
Some |
|
Levosalbutamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Levalbuterol 45mcg hfa metered dose aerosol inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levosalbutamol |
Inferred relationship |
Some |
|
Levosalbutamol tartrate (substance) |
Is a |
False |
Levosalbutamol |
Inferred relationship |
Some |
|
Levosalbutamol hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Levosalbutamol |
Inferred relationship |
Some |
|
Levosalbutamol tartrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Levosalbutamol |
Inferred relationship |
Some |
|
Product containing only levosalbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Levosalbutamol sulfate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Levosalbutamol |
Inferred relationship |
Some |
|
Ipratropium and levosalbutamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Product containing ipratropium and levosalbutamol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurised solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Ipratropium- and levosalbutamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Product containing only ipratropium and levosalbutamol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely ipratropium bromide 40 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 100 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Beclometasone- and levosalbutamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Product containing only beclometasone and levosalbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Beclometasone- and levosalbutamol-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Beclometasone and levosalbutamol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 50 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurised solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Product containing levosalbutamol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |
Levosalbutamol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levosalbutamol |
Inferred relationship |
Some |
1 |